Psychiatry · Chicago, IL
NPI
1568812253
Since 2016
Specialty
Psychiatry
Code 2084P0800X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2233 W Division St
Chicago, IL, 60622
Phone (916) 342-7015
Groups this clinician bills Medicare through
Medicare paid, 2024
$128K
2,783 services
Medicare patients, 2024
659
Average age 70
Drug cost, 2024
$1.9M
31,441 prescriptions
Company payments, 2024
$49.18
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Krushen Pillay was code 99490 (chronic, principal, and transitional care management), 606 times for 142 patients. In total Krushen Pillay billed 2,783 services in 25 codes, and Medicare paid $128K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 606 | 142 | $45.37 | $27K |
| 99439 Chronic, Principal, and Transitional Care Management | Facility | 351 | 136 | $24.72 | $8,678 |
| 99490 Chronic, Principal, and Transitional Care Management | Facility | 292 | 144 | $35.45 | $10K |
| 99308 SNF E&M | Facility | 281 | 227 | $51.38 | $14K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 270 | 103 | $33.63 | $9,080 |
| 90833 Psychotherapy - Nongroup | Facility | 228 | 187 | $44.38 | $10K |
| 99309 SNF E&M | Facility | 179 | 151 | $72.83 | $13K |
| 99309 SNF E&M | Office | 89 | 88 | $76.86 | $6,841 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 84 | 22 | $44.94 | $3,775 |
| 99308 SNF E&M | Office | 68 | 65 | $53.07 | $3,609 |
| 90833 Psychotherapy - Nongroup | Office | 64 | 60 | $51.18 | $3,276 |
| 90792 Psychotherapy - Nongroup | Facility | 39 | 39 | $121.18 | $4,726 |
| 99426 Chronic, Principal, and Transitional Care Management | Facility | 33 | 13 | $34.26 | $1,131 |
| 99427 Chronic, Principal, and Transitional Care Management | Office | 24 | 12 | $33.46 | $803 |
| 99487 Chronic, Principal, and Transitional Care Management | Facility | 23 | 20 | $65.73 | $1,512 |
By year: 2022 $138K for 1,802 services; 2023 $98K for 1,658 services; 2024 $128K for 2,783 services.
Medicare prescription drug claims, 2024
In 2024, the drug Krushen Pillay prescribed most often to Medicare patients was Trazodone Hcl, with 2,241 prescriptions and refills. In total Krushen Pillay wrote 31,441 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trazodone Hcl Generic | 2,241 | 2,242 | 253 | $18K |
| Olanzapine Generic | 2,063 | 2,064 | 324 | $42K |
| Sertraline Hcl Generic | 2,000 | 2,002 | 218 | $18K |
| Risperidone Generic | 1,774 | 1,777 | 173 | $19K |
| Quetiapine Fumarate Generic | 1,646 | 1,649 | 190 | $25K |
| Clozapine Generic | 1,582 | 1,582 | 103 | $115K |
| Divalproex Sodium Generic | 1,342 | 1,342 | 132 | $30K |
| Mirtazapine Generic | 1,233 | 1,236 | 149 | $19K |
| Benztropine Mesylate Generic | 1,188 | 1,191 | 77 | $11K |
| Duloxetine Hcl Generic | 1,079 | 1,080 | 77 | $20K |
| Fluoxetine Hcl Generic | 888 | 888 | 60 | $7,037 |
| Escitalopram Oxalate Generic | 867 | 873 | 120 | $8,043 |
| Haloperidol Generic | 848 | 848 | 170 | $22K |
| Lorazepam Generic | 815 | 818 | 245 | $9,138 |
| Buspirone Hcl Generic | 749 | 749 | 82 | $8,164 |
Brand drugs: 578 claims; generic drugs: 30,863 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Krushen Pillay $49.18 ($49.18 in general payments such as food, travel and fees) from 1 company. The largest payer was Otsuka Pharmaceutical Development & Commercialization, Inc. with $49.18.
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 2 | $49.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.